A resurgence in live events and sports programming on streaming platforms, coupled with the expansion of self-serve and ...

FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come.

ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the“Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...

Canada, an innovative health services company transforming the delivery of evidence-based care, today shared the latest enhancements to mental health support available on the Kii Platform. The ...

Former House Speaker Nancy Pelosi said back in 2022 the Senate would soon vote on a bill banning members of Congress from trading individual stocks. More than two years later, Pelosi is no longer ...

CHICAGO, April 28, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop ...

Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6. In the last reported quarter, the company’s adjusted loss of 18 cents was wider than the Zacks Consensus ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine with a market capitalization of $9.15 billion, announced the launch of Tempus Loop, a new platform designed to ...

The new, proprietary target discovery platform integrates RWD, human biological modeling, and CRISPR screens to accelerate novel target identification Tempus AI, Inc. (NASDAQ: TEM), a technology ...